Literature DB >> 26974603

Breakable mesoporous silica nanoparticles for targeted drug delivery.

Laura Maggini1, Ingrid Cabrera1, Amparo Ruiz-Carretero1, Eko A Prasetyanto1, Eric Robinet2, Luisa De Cola3.   

Abstract

"Pop goes the particle". Here we report on the preparation of redox responsive mesoporous organo-silica nanoparticles containing disulfide (S-S) bridges (ss-NPs) that, even upon the exohedral grafting of targeting ligands, retained their ability to undergo structural degradation, and increase their local release activity when exposed to a reducing agent. This degradation could be observed also inside glioma C6 cancer cells. Moreover, when anticancer drug-loaded pristine and derivatized ss-NPs were fed to glioma C6 cells, the responsive hybrids were more effective in their cytotoxic action compared to non-breakable particles. The possibility of tailoring the surface functionalization of this hybrid, yet preserving its self-destructive behavior and enhanced drug delivery properties, paves the way for the development of effective biodegradable materials for in vivo targeted drug delivery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974603     DOI: 10.1039/c5nr09112h

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  28 in total

1.  In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition.

Authors:  Seyyed Pouya Hadipour Moghaddam; Raziye Mohammadpour; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2019-08-26       Impact factor: 9.776

2.  Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.

Authors:  Seyyed Pouya Hadipour Moghaddam; Mostafa Yazdimamaghani; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2018-04-19       Impact factor: 9.776

3.  Redox-Responsive Polysulfide-Based Biodegradable Organosilica Nanoparticles for Delivery of Bioactive Agents.

Authors:  Seyyed Pouya Hadipour Moghaddam; Jiban Saikia; Mostafa Yazdimamaghani; Hamidreza Ghandehari
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-13       Impact factor: 9.229

Review 4.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 5.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

6.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

7.  Orienting the Pore Morphology of Core-Shell Magnetic Mesoporous Silica with the Sol-Gel Temperature. Influence on MRI and Magnetic Hyperthermia Properties.

Authors:  Alexandre Adam; Ksenia Parkhomenko; Paula Duenas-Ramirez; Clémence Nadal; Geoffrey Cotin; Pierre-Emmanuel Zorn; Philippe Choquet; Sylvie Bégin-Colin; Damien Mertz
Journal:  Molecules       Date:  2021-02-12       Impact factor: 4.411

8.  Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.

Authors:  Yi Wei; Li Gao; Lu Wang; Lin Shi; Erdong Wei; Baotong Zhou; Li Zhou; Bo Ge
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.

Authors:  Binlong Chen; Wenbing Dai; Bing He; Hua Zhang; Xueqing Wang; Yiguang Wang; Qiang Zhang
Journal:  Theranostics       Date:  2017-01-07       Impact factor: 11.556

10.  Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.

Authors:  Binh Thanh Vu; Sophia Allaf Shahin; Jonas Croissant; Yevhen Fatieiev; Kotaro Matsumoto; Tan Le-Hoang Doan; Tammy Yik; Shirleen Simargi; Altagracia Conteras; Laura Ratliff; Chiara Mauriello Jimenez; Laurence Raehm; Niveen Khashab; Jean-Olivier Durand; Carlotta Glackin; Fuyuhiko Tamanoi
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.